Outlook Therapeutics, Inc.
OTLK
DELAYED 1 MONTH
9 insider filings · Latest: Jul 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Jul 29 7:19 PM | Faisal Ghiath SukhtianDirector | Purchase | 95,398 | $1.05 | $100.0K | 220,972(D) | View → |
| Jun 2, 2026 | Jun 3 10:03 PM | Yezan Munther HaddadinDirector | Purchase | 29,000 | $0.8326 | $24.1K | 66,167(D) | View → |
| May 28, 2026 | Jun 2 1:30 AM | Ghiath M. SukhtianDirector, 10% Owner | Purchase | 8,539,709 | $0.5855 | $5.0M | 22,092,068(I) | View → |
| May 27, 2026 | May 27 7:29 PM | Faisal Ghiath SukhtianDirector | Purchase | 122,174 | $0.4093 | $50.0K | 125,574(D) | View → |
| May 26, 2026 | May 27 7:24 PM | Yezan Munther HaddadinDirector | Purchase | 34,000 | $0.44 | $15.0K | 37,167(D) | View → |
| May 26, 2026 | May 27 7:20 PM | Randy H ThurmanDirector | Purchase | 5,000 | $0.429 | $2.1K | 5,593(D) | View → |
| May 26, 2026 | May 27 7:15 PM | Kurt J HilzingerDirector | Purchase | 400,000 | $0.4413 | $176.5K | 423,655(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Jul 23 11:49 PM | Lawrence A KenyonDirector, Chief Financial Officer | Grant/Award | 210,078 | $1.43 | 210,078(D) | View → |
| Jul 21, 2026 | Jul 23 11:34 PM | Robert Charles JahrDirector, Chief Executive Officer | Grant/Award | 100,000 | $1.43 | 100,000(D) | View → |
| May 28, 2026 | Jun 2 1:30 AM | Ghiath M. SukhtianDirector, 10% Owner | H | 15,488,570 | $2.26 | 0(I) | View → |
| May 28, 2026 | Jun 2 1:30 AM | Ghiath M. SukhtianDirector, 10% Owner | Purchase | 15,488,570 | $0.5855 | 8,571,428(I) | View → |